title: The meddling microbes midst our medicines.
abstract: It is not surprising that the complex metabolic machinery of the gut microbiome has accidental, or directed, ability to alter our medicines and influence their efficacy. What is not known is the extent to which this has contributed to drug failures or contraindications, or to the derailment of clinical trials. Some studies are unraveling the mechanisms by which the microbiota alter specific drugs, such as digoxin, and contribute to variations in efficacies between patient populations. Microbiome profiling, therefore, may well become an inevitable arm of all clinical trials in the future.
authors: School of Animal and Comparative Biomedical Sciences; University of Arizona; Tucson, AZ USA.
authors: Vk
authors: V
authors: Viswanathan
mesh_terms: D001419:Bacteria / Q000378:metabolism*; D004358:Drug Therapy; D041981:Gastrointestinal Tract / Q000378:metabolism / Q000382:microbiology*; D006801:Humans; D008511:Medicine; D064307:Microbiota; D004364:Pharmaceutical Preparations / Q000378:metabolism*
chemical_list: D004364:Pharmaceutical Preparations
keywords: Eggerthella lenta; digoxin; medicines; microbiota
references: Science. 2012 Jun 8;336(6086):1253-5
references: 22674325
references: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14187-8
references: 19706501
references: Gut. 1989 Jul;30(7):971-7
references: 2759492
references: Science. 2013 Jul 19;341(6143):295-8
references: 23869020
references: N Engl J Med. 1981 Oct 1;305(14):789-94
references: 7266632
references: Science. 1983 Apr 15;220(4594):325-7
references: 6836275
references: Gastroenterology. 1988 Jul;95(1):117-23
references: 3371607